I would like to write down my insights for future reference.

 

Today is 19 June End of Market.

 

Firstly, my alert came from a technical analysis alert.

 

There has been consolidation of this stock at 0.01 level and today's

close resulted in a hammer formation which is a bullsih signal at the

valley of the recent rally.

The day before, the stock tried to make a run upwards but failed. This

adds on to the bullishness.

 

This is confirmed by 2 websites.

 

http://www.stockta.com/cgi-bin/analysis.pl?symb=IGNT&num1=1&cobrand=&...

 

and

 

http://www.americanbulls.com/StockPage.asp?CompanyTicker=IGNT&MarketT...

 

American bulls give it a buy-if. To be confirmed on Monday, should

monday experience a high demand.

 

SECONDLY, FUNDAMENTAL views.

 

IGNT is expected to succeed with their latest canula which is cheaper

at $4.75 than average and has an added advantage of a flow meter that

no other canula has.

 

It has increased its inital order which is a positive sign that there

is high demand expectation.

 

My predicted revenue is a conservative $100mln, half of what their CEO

expects.

 

This Canula has to be replaced forthnightly which translate to high

turnover. And they are reimbursable by medicare, so there is no

obstacles that hinder IGNT.

 

A buyout is possible using the valuation the CEO expects at $200mln

revenue.

 

Let's just talk about the $100mln revenue. With expected trading to be

3X the revenue, and outstanding shares at 520mln. $300mln / 520mln =

$0.577

 

Now, you do realise how undervalued INGEN is?

 

With Technical analysis saying BUY, and fundamental analysis saying

undervalued, I think it is no mistake to purchase this stock at this

level.

 

Should the shorters further short this stock, average it, and buy at

lower price.

 

Now I am looking forward to purchase 1mln shares of this at a cheap

price of only $9000.

 

My target level is the conservative $100mln revenue, hence $0.577,

while their CEO estimate of $250mln revenue, translates to $1 ++.

Hopefully the CEO is right, and I will finally see $1mln in my life.

SPNG, not too late to enter at 23.5 cts! Hurry, it's a steal. STRONG BUY recommendation

Don't be too late to enter SPNG. Now is still cheap.

 

It will become a tradeable stock at $1 and ppl will be playing it.

 

Remember that stock prices always come to equilibrium with the company

worth.

 

Honestly, ask yourself how much you are willing to pay for the entire

spongetech business.

 

$200mln (current price) ? the owner will slap you, because they have

spent 10 years to build up a company and this is how much you offer?

 

$1bln? Well, he may think for awhile, this sounds better, but he may

not want to sell it at that price.

 

Why? Spongetech has just burst out of its infancy state. Now it's

clearly destined for growth. The current product line only has 25

products.

 

Imagine how many products they will have soon. Using other brand names

too with it as the parent company. Have you seen a sponge facial

product? Sponge Facial Toner? How about a sponge glass cleaner? Sponge

mop? Sponge Air freshener? Spongebob...

 

There is going to be about 100 products in the pipeline as said by

their CEO. So we have to see the possible future earnings of this

company.

 

Nickelodeon believes SPONGEBOB alone would generate $20mln revenue.

Carwash could generate $100mln revenue, Uncle Norman Petcare could

generate $20mln revenue. With the future, other products may generate

additional $20mln at the very least.

 

So by 2010, expect 20+100+20+20= 160mln revenue. Profit margin is

super high. They could profit 30% which is $48mln. EPS is thus = $0.06

by 2010.

 

Expect that to rise to $0.50 by 2011. Growth is estimated at 80% per

year.

 

Hence if I were the owner of Spongetech, I will sell this at $5bln.

 

Can you see with a discounted P/E of 10 for this sector, which will

rise in times of good economy to 25, this stock with 2010 EPS estimate

should trade at $0.60 to $1.5

 

With 2011 estimate. expect it to be a $5 stock.

 

I predict a lot of subsidiary brands to be formed by spongetech

handling the various cleaning proudcts using their delievery system.

 

Thus I will disclose my holdings.

 

Bought a bit late at $0.036, $0.044, $0.56, $0.08, $0.10, $0.22,

$0.225, $0.235

 

You may wonder why I keep buying as the price went up.

 

Well, I am more confident that this stock is not a pump and dump stock

like those I have seen elsewhere such as ETGG, and the likes.

And I had no money, so I had to divest my shares in CITIBANK, BAC,

MGM, LVS, just to buy SPNG.

All together at the current price of $0.234, I have $300k worth of

SPNG. I am holding this for a long term ride with the company.

 

Expect the company to buyback shares when they make more profit. And

soon, we may be receiving dividends.

 

Look at Proctor and Gamble CAP, its 151billion! Surely spongetech is

able to steal some of its market.

 

I believe this is somewhat like the next MSFT, but of course not as

big as microsoft, but has potential to keep growing. I missed MSFT

because I wasnt born yet, but now I will not miss SPNG. Spongetech is

the future. Every household will be using Spongetech product. May it

be a sponge or some cleaning device. I wouldnt be surprised if they

could come out with a Sponge robo cleaner. Perhaps in the shape of

SpONGE BOB haha. Never know could happen.

NEW TRADE ALERT - SPNG buy at 0.06

This is stock that I have been monitoring for a long time.

 

SPNG

 

Strong buy at market open, anywhere from 0.04-0.06 is a good price to enter.

 

Reasons.

 

-        Wants to be listed in NASDAQ

-        Has  very high revenue this year due to recent large orders

-        Has orders from COSCO

-        Waiting for orders from WALMART, Walgreen

-        Has a new product (SPONGEBOB Sponge) which is promising

-        Low market capitalization

 

TARGET- 0.50

 

10X, risk -50%.

 

VERY GOOD BUY

 

$10,000 in this too for me.

ANTIGENICS (AGEN) study

3 Super Reasons to buy AGEN now at $0.90

Park $10,000 in AGEN and you can be a millionaire in 2011.

1. The drug is already approved in Russia and is awaiting commercialisation which is very imminent. Once drug goes on sale in Russia, I am expecting this stock to be trading at 500 million dollars market capitalisation. Why, because, this is what i found.

"An estimated 16,000 Russians will be diagnosed with kidney cancer and 8011 will die of the disease in the Russia in 2008. 
Renal cell carcinoma (RCC) comprises approximately 4% and 2.7% of all malignancies in men and women, respectively."

From a site which i forgot, ONCOPHAGE course cost $10,000 to $20,000.

So let's say half of the cancer patients take up oncophage, the profit is expected to be 8000 X $10000 = $80,000,000 per year. (this is assuming the least possible result)

Currently, there is about 80 million outstanding shares. Earnings per share could be about $1 per share. Based on standard P/E ratio of at least 5, this stock should be trading at $5.

2. AGEN has submitted its marketing plan to European Union. If approved, look at this from wikipedia.

"The most recent estimates of incidence of kidney cancer suggest that there are 63,300 new cases annually in the EU25."

let's say half again take up oncophage. 30000 X $10000 = $300,000,000

It's a $300million dollar profit. I am sure by then the outstanding shares would have increased to about 100million shares.

So that will allow the stock to rise to $15. 

"In the United States in 2008, these two types together are estimated to cause 54,390 new cases and 13,010 deaths."

Possible to be $30 by next year.

3. ONCOPHAGE is also being investigated in phase 3 to treat melanoma.

"Around 160,000 new cases of melanoma are diagnosed worldwide each year."

This will help AGEN to rise another $30. Plus a stock split. maybe. 

Target 2011 = $60 X 2 due to stock split.

Buying at $1, this stock is able to get you 120X in 2 years.

$10,000 = $1.2 million

"Oncophage has been granted fast track and orphan drug designations from the US Food and Drug Administration for kidney cancer and metastatic melanoma. Oncophage has orphan drug status for kidney cancer from the European Medicines Agency."

It's a ORPHAN drug. Which means it is the only drug available to vaccinate against reoccurrence of CANCER.

So the possible target patients are 200,000 (kidney cancer) + 160,000 (melanoma).

$10,000 Portfolio (CANCER HOPE)

Stock.            Amt.        Price to enter.  

CTIC          3500            $1.8                

AGEN        4000            $0.90   

I have already bought these 2 stocks at $1.18 (CTIC) and $0.69 (AGEN).

But I am planning to increase my portfolio with these 2 stocks.

CTIC is gaining strength due to its novel drug PIXANTRONE.

AGEN has the best therapeutic vaccine which is awaiting European Union approval. It is called ONCOPHAGE.

The expected long term gain for CTIC is $50 by year end, and for AGEN, it is $15 by year end.